Related Experiment Video
Updated: Jul 6, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
A da Vinci robot system can make sense for a mature laparoscopic prostatectomy program
Peter L Steinberg1, Paul A Merguerian, William Bihrle
1Section of Urology Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA.
JSLS : Journal of the Society of Laparoendoscopic Surgeons
|April 12, 2008
Summary
Transitioning from laparoscopic radical prostatectomy (LRP) to robotic-assisted radical prostatectomy (RAP) is feasible for high-volume programs. However, the significant cost of robotic systems impacts profitability, especially for lower-volume centers.
Area of Science:
- Urology
- Surgical Technology
- Health Economics
Background:
- Laparoscopic radical prostatectomy (LRP) is a mature surgical technique.
- Robotic-assisted radical prostatectomy (RAP) utilizes advanced robotic systems like the da Vinci robot.
- Evaluating the financial implications of transitioning from LRP to RAP is crucial for healthcare institutions.
Purpose of the Study:
- To provide recommendations for transitioning from LRP to RAP.
- To analyze the cost-benefit of adopting the da Vinci robot for prostatectomy.
- To assess the financial impact on established LRP programs.
Main Methods:
- A cost-benefit analysis was conducted.
- The study modeled the financial impact of purchasing a da Vinci robot, including initial cost, annual service contract, and per-case disposable expenses.
- The analysis focused on a mature laparoscopic prostatectomy program.
Main Results:
- Seventy-eight annual cases are required to cover the costs of a purchased robot; only 20 cases are needed if the robot is donated.
- Profitability is achievable once robot costs are recouped, with increased income correlating with higher caseloads.
- Programs performing fewer than 25 cases annually may not find purchasing a robot financially viable.
Conclusions:
- High-volume LRP programs can transition to RAP while maintaining profitability, though overall income may be lower than with LRP due to robot costs.
- Robot acquisition is not financially sensible for low-volume programs.
- Hospitals must weigh the financial costs against potential market advantages and intangible benefits of robotic surgery when deciding on RAP adoption.
